Neu! Privatansicht
BetaNeu! Privatansicht
BetaNeu! Privatansicht
BetaNeu! Privatansicht
BetaNeu! Privatansicht
BetaNeu! Privatansicht
BetaHospitalization costs for the MARS treated group were greater than that for the controls (€31,539 vs. €7,543) and similarly direct cost at 3-year follow-up (€8,493 vs. €5,194). Nevertheless, after adjusting mortality rate, the annual cost per patient was €12,092 for controls and €5,827 for MARS group; also in the latter, they found an incremental cost-effectiveness ratio of 31.448 ...
Wikipedia